| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |